TY  - GEN
AU  - Martins,Renato G
AU  - Parvathaneni,Upendra
AU  - Bauman,Julie E
AU  - Sharma,Anand K
AU  - Raez,Luis E
AU  - Papagikos,Michael A
AU  - Yunus,Furhan
AU  - Kurland,Brenda F
AU  - Eaton,Keith D
AU  - Liao,Jay J
AU  - Mendez,Eduardo
AU  - Futran,Neal
AU  - Wang,David X
AU  - Chai,Xiaoyu
AU  - Wallace,Sarah G
AU  - Austin,Melissa
AU  - Schmidt,Rodney
AU  - Hayes,D Neil
TI  - Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial
SN  - 1527-7755
PY  - 2013///0531
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Squamous Cell
KW  - genetics
KW  - Chemoradiotherapy
KW  - adverse effects
KW  - Cisplatin
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Exanthema
KW  - chemically induced
KW  - Female
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Male
KW  - Pain
KW  - Quinazolines
KW  - Remission Induction
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2012.46.3299
ER  -